Dana-Farber Cancer Institute and Sanford-Burnham Medical Research Institute sign license agreement with Genentech (News-Medical-Net)
February 9th, 2010 by admin
Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current …
Read more from the original source:
Dana-Farber Cancer Institute and Sanford-Burnham Medical Research Institute sign license agreement with Genentech (News-Medical-Net)
Posted in Uncategorized